@article{fce6d4e85a004130ad60c04010c24712,
title = "Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas",
keywords = "BCL2-inhibitors, BTK-inhibitors, XPO1-inhibitors, diffuse large B cell lymphoma, bispecific antibodies, checkpoint inhibitors, chimeric antigen receptor-T cells, antibody–drug conjugates, BCL2-inhibitors, BTK-inhibitors, XPO1-inhibitors, diffuse large B cell lymphoma, bispecific antibodies, checkpoint inhibitors, chimeric antigen receptor-T cells, antibody–drug conjugates",
author = "Francesco D'Alo' and Silvia Bellesi and Elena Maiolo and Eleonora Alma and Flaminia Bellisario and Rosalia Malafronte and Marcello Viscovo and Fabrizia Campana and Stefan Hohaus",
year = "2024",
doi = "10.3390/cancers16122243",
language = "English",
volume = "16",
pages = "N/A--N/A",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
}